Tag Archives: Drug

Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals

Use Our Content This story can be republished for free (details). Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs. But the administration’s plan for drug rebates, announced Thursday, would end the pharmaceutical business as usual, shift billions in revenue and… Read More »